Menu
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Wall Street Thinks This 7.6% Yielding Stock Has Up to 91% Upside. Should You Buy?


Most of the time, high-yielding stocks aren't coupled with high target prices from Wall Street. Instead, high yields usually convey market uncertainty, which is usually tied to a lower price target. However, AT (NYSE: T) has both a high 7.6% yield and a price target of $28 from Ivan Feinseth at Tigress Financial, indicating a 91% upside.

While that's the top level, an average of 20 analysts puts the one-year target at $19, indicating nearly a 30% upside. No matter how you slice it, at's stock looks undervalued, at least according to analysts. Throw in a mouth-watering yield, and there seem to be a lot of reasons to purchase at stock. But should you actually do it? Let's find out.

AT is the leading telecom provider in the U.S., accounting for about 46% of all subscriptions as of second-quarter 2023. However, because roughly 85% of people in the U.S. now have a smartphone, there's not a lot of opportunity to grow rapidly. On the flip side, because telecom companies have practically become tech utilities, there isn't a lot of revenue variance either.

Continue reading


Source Fool.com

Allergy Therapeutics PLC Stock

€0.051
5.150%
Allergy Therapeutics PLC dominated the market today, gaining €0.003 (5.150%).

Like: 0
T
Share

Comments